These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8925804)

  • 1. Effect of a high-protein meal on gabapentin pharmacokinetics.
    Gidal BE; Maly MM; Budde J; Lensmeyer GL; Pitterle ME; Jones JC
    Epilepsy Res; 1996 Feb; 23(1):71-6. PubMed ID: 8925804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral gabapentin disposition in patients with epilepsy after a high-protein meal.
    Benetello P; Furlanut M; Fortunato M; Baraldo M; Pea F; Tognon A; Testa G
    Epilepsia; 1997 Oct; 38(10):1140-2. PubMed ID: 9579961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin absorption: effect of mixing with foods of varying macronutrient composition.
    Gidal BE; Maly MM; Kowalski JW; Rutecki PA; Pitterle ME; Cook DE
    Ann Pharmacother; 1998 Apr; 32(4):405-9. PubMed ID: 9562133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability.
    Gidal BE; Radulovic LL; Kruger S; Rutecki P; Pitterle M; Bockbrader HN
    Epilepsy Res; 2000 Jul; 40(2-3):123-7. PubMed ID: 10863139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma.
    Stewart BH; Kugler AR; Thompson PR; Bockbrader HN
    Pharm Res; 1993 Feb; 10(2):276-81. PubMed ID: 8456077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbil.
    Lal R; Sukbuntherng J; Luo W; Huff FJ; Zou J; Cundy KC
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):120-8. PubMed ID: 20137764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of a pharmacokinetic interaction between phenobarbitone and gabapentin.
    Hooper WD; Kavanagh MC; Herkes GK; Eadie MJ
    Br J Clin Pharmacol; 1991 Feb; 31(2):171-4. PubMed ID: 2049232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of age and gender on single-dose pharmacokinetics of gabapentin.
    Boyd RA; Türck D; Abel RB; Sedman AJ; Bockbrader HN
    Epilepsia; 1999 Apr; 40(4):474-9. PubMed ID: 10219274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol.
    Eldon MA; Underwood BA; Randinitis EJ; Sedman AJ
    Neurology; 1998 Apr; 50(4):1146-8. PubMed ID: 9566412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
    Radulovic LL; Türck D; von Hodenberg A; Vollmer KO; McNally WP; DeHart PD; Hanson BJ; Bockbrader HN; Chang T
    Drug Metab Dispos; 1995 Apr; 23(4):441-8. PubMed ID: 7600909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose gabapentin pharmacokinetics and safety in healthy infants and children.
    Haig GM; Bockbrader HN; Wesche DL; Boellner SW; Ouellet D; Brown RR; Randinitis EJ; Posvar EL
    J Clin Pharmacol; 2001 May; 41(5):507-14. PubMed ID: 11361047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonic absorption of antiepileptic agents.
    Stevenson CM; Kim J; Fleisher D
    Epilepsia; 1997 Jan; 38(1):63-7. PubMed ID: 9024185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin enhances the analgesic effect of morphine in healthy volunteers.
    Eckhardt K; Ammon S; Hofmann U; Riebe A; Gugeler N; Mikus G
    Anesth Analg; 2000 Jul; 91(1):185-91. PubMed ID: 10866910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin.
    Ben-Menachem E; Persson LI; Hedner T
    Epilepsy Res; 1992 Mar; 11(1):45-9. PubMed ID: 1373372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of gabapentin.
    McLean MJ
    Neurology; 1994 Jun; 44(6 Suppl 5):S17-22; discussion S31-2. PubMed ID: 8022536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of pregabalin in rat intestine and Caco-2 monolayers.
    Jezyk N; Li C; Stewart BH; Wu X; Bockbrader HN; Fleisher D
    Pharm Res; 1999 Apr; 16(4):519-26. PubMed ID: 10227706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saturable transport of gabapentin at the blood-brain barrier.
    Luer MS; Hamani C; Dujovny M; Gidal B; Cwik M; Deyo K; Fischer JH
    Neurol Res; 1999 Sep; 21(6):559-62. PubMed ID: 10491815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the autoradiographic binding distribution of [3H]-gabapentin with excitatory amino acid receptor and amino acid uptake site distributions in rat brain.
    Thurlow RJ; Hill DR; Woodruff GN
    Br J Pharmacol; 1996 Jun; 118(3):457-65. PubMed ID: 8762065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of gabapentin in anuric subjects on hemodialysis.
    Wong MO; Eldon MA; Keane WF; Türck D; Bockbrader HN; Underwood BA; Sedman AJ; Halstenson CE
    J Clin Pharmacol; 1995 Jun; 35(6):622-6. PubMed ID: 7665723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.
    Gordi T; Hou E; Kasichayanula S; Berner B
    Clin Ther; 2008 May; 30(5):909-16. PubMed ID: 18555937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.